Axsome Therapeutics Stock News & Updates
[WKN: A2AA7B | Symbol: AXSM]Axsome Therapeutics Biotech Company Impresses with Strong Pipeline!
Axsome Therapeutics Impresses with Strong Quarter and Accelerated FDA Review
Axsome Therapeutics (AXSM) has good chances of a successful trend continuation with two pivotal news...
Analysts' Top 5 Price Targets of January 16, 2025
Fair Isaac [US3032501047] Jefferies confirms Buy rating and adjusts the price target from $2100 to...
Axsome Pharmaceuticals - Biotech company achieves important breakthrough in Alzheimer’s treatment!
Business Driver: The US biotech company Axsome Therapeutics (AXSM) specializes in the development of...
Analysts' Top 5 Price Targets of October 1, 2025
MongoDB [US60937P1066] Wells Fargo starts coverage with Overweight and a price target of $430...
5 Rising Biopharma Stocks with over 50% Annual Growth Potential
Dear readers, Last week, I introduced five biopharma stocks that have taken off in recent weeks. It...
Analysts' Top 5 Price Targets of August 21, 2025
Axsome Therapeutics [US05464T1043] RBC Capital confirms Buy rating with a price target of $189...
Axsome Therapeutics: High Demand for Medications for the Treatment of Depression and Daytime Sleepiness!
Biotechnology companies are currently attracting increasing interest from investors. Particularly those...
Analysts' Top 5 Price Targets of July 3, 2025
AppLovin [US03831W1080]: Wedbush confirms Outperform rating with a price target of $620 (85% upside potential)...
Axsome Therapeutics is Looking Forward to Significant Market Launches and FDA Approvals – Wells Fargo Sees 40% Potential!
Axsome Therapeutics (AXSM) aims to reach over 150 million people in the USA with treatment solutions...
Analysts' Top 5 Price Targets of May 6, 2025
Upwork [US91688F1049]: Roth MKM reaffirms Buy rating with a price target of $19 (30% upside potential)...
Analysts' Top 5 Price Targets of April 7, 2025
Axsome Therapeutics [US05464T1043]: Jefferies starts coverage with a Buy rating and a price target of...